Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
38.62
-0.01 (-0.03%)
Nov 7, 2025, 3:07 PM EST - Market open
KNSA Market Cap
KNSA has a market cap or net worth of $2.93 billion as of November 7, 2025. Its market cap has increased by 53.37% in one year.
Market Cap
2.93B
Enterprise Value
2.52B
1-Year Change
53.37%
Ranking
Category
Stock Price
$38.62
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $2.93B, an increase of 210.37%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 2.93B | 105.02% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |